New heart ultrasound dye shows promise in early safety trial
NCT ID NCT04185246
First seen Nov 18, 2025 · Last updated May 23, 2026 · Updated 21 times
Summary
This study tested a new contrast agent called NH002 to see if it is safe for use in heart ultrasounds. It involved 36 adults with heart disease who received different doses of the agent. The main goal was to check for side effects and monitor vital signs, while also seeing how well it improved heart images.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Taipei Mackay Memorial Hospital
Taipei, 10449, Taiwan
-
Taipei Veterans General Hospital
Taipei, 11217, Taiwan
Conditions
Explore the condition pages connected to this study.